Loading...
Loading...
By MBN Staff - Mon, 07/21/2025 - 17:12
The GPCR targeting market is set to grow to US$6.1 billion by 2029, driven by chronic diseases and advances in drug discovery technologies.
https://mexicobusiness.news/tag/biopharmaceuticals
More Health
By MBN Staff - Fri, 07/04/2025 - 09:45
Mexico launches new pharma investments to boost drug production and reduce import reliance.
By MBN Staff - Fri, 05/02/2025 - 08:22
Galmed signs a global deal to develop a sublingual Semaglutide formulation, targeting Mexico and international markets.
By MBN Staff - Fri, 04/25/2025 - 15:26
Lilly’s oral GLP-1 drug orforglipron met key goals in a Phase 3 trial, showing significant A1C and weight reductions in type 2 diabetes patients.
By Alejandro Luna - Wed, 02/26/2025 - 07:00
Mexico must regulate clinical data protection to comply with treaties, boost innovation, and ensure regulatory certainty - Armando Arenas Reyes.
By Juan Luis Serrano Leets - Thu, 12/12/2024 - 16:00
With a newly designated head commissioner, Juan Luis Serrano looks at the key challenges COFEPRIS will likely face in 2025.
By MBN Staff - Fri, 08/16/2024 - 16:58
The FDA approves Gilead's Livdelzi for PBC, a key addition to liver disease treatments, with projected peak sales of US$847 million.
By Anmol Motwani - Thu, 08/24/2023 - 10:35
From the impact of Hurricane Hilary in Baja California to the vigilant global monitoring of emerging variants and much more in this week’s round-up!
By Cristobal Thompson - Mon, 04/17/2023 - 10:00
Stakeholder collaboration can ensure the COVID-19 lessons shape a future where everyone is better protected from pandemics, writes Cristóbal Thompson.
By Cristobal Thompson - Wed, 02/15/2023 - 13:00
The inspiring history of progress will continue to be written, with biopharmaceutical innovation taking center stage, writes Cristobal Thompson.
